On June 30, Marvell Technology rose 3.43% in regular trading, trading at $287.96/share, with turnover of $11.88 billion. The stock rebounded sharply after multiple top-tier investment banks raised their target prices in rapid succession.
On the news front, UBS significantly raised its target price from $230 to $340 while maintaining a Buy rating, citing strong long-term growth prospects for the company's CXL chip business, with projected CXL revenue reaching $20 billion by 2028. Bank of America Securities raised its target from $240 to $365, and Stifel lifted its target from $321 to $350. UBS also revised total revenue forecasts to $16.8 billion and $23.9 billion for fiscal 2027 and 2028, respectively, driven by XPU connectivity and CPU business increments.
The broader semiconductor sector provided tailwinds, with the Philadelphia Semiconductor Index rising 1.9%. Options market sentiment also turned bullish, with a notable $749,700 call order targeting the $300 strike price, reflecting directional conviction to the upside. The stock had previously corrected over 20% in the prior week before this rebound.
(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)
Comments